ERBB2 and breast carcinoma: Their work allowed cancer cell isolation/enrichment, optical imaging, multiplex SERS detection for four cancer biomarkers (EpCAM, HER2, CD44, and IGF1R), as well as molecular profiling of various breast cancer cell lines.